The research team, based at the University of Colorado Boulder, built their platform around a technology called the Nano-Engineered Surface Technology, or NEST, device. At its heart is a silicon chip etched with parallel microfluidic channels, each studded with a single sharp nanostructure the researchers call a nanolancet. The tip of each nanolancet is roughly 100 nanometers wide and 2.4 micrometers tall, and it is positioned so that a cell flowing past at high speed is impaled precisely up to the surface of its nucleus. The device is fabricated using standard semiconductor processes—photolithography, deep reactive ion etching, and anodic bonding of silicon to borosilicate glass—meaning it could, in principle, be manufactured at scale like any computer chip.

The numbers involved are remarkable. When HeLa cells are driven through the device at an inlet pressure of 28 pounds per square inch, the fluid moves at roughly 3,000 millimeters per second past the nanolancet, and the system can process 200,000 cells in under two seconds. Confocal microscopy confirmed that the resulting wounds are far larger than those produced by conventional techniques such as laser ablation or micropipette aspiration: the average plasma membrane pore measured 7.4 micrometers in diameter, while the average nuclear envelope rupture measured 2.6 micrometers. Crucially, the damage is survivable. Flow cytometry showed that about 60 percent of cells had their membranes permeabilized, yet roughly 90 percent of the population recovered and remained viable after treatment.

That combination—large, controlled wounds delivered synchronously to entire populations while preserving viability—is what makes the platform scientifically powerful. Existing methods for studying membrane repair either wound one cell at a time with exquisite temporal precision or generate only small punctures that do not reflect the severe mechanical disruption cells experience during metastatic migration. With NEST, the researchers could fix cells at defined time points after a shared wounding event and build statistically robust pictures of the repair response across thousands of cells, an approach that also makes it possible to detect rare or heterogeneous behaviors that would vanish in small samples.

To track the repair response, the team focused on CHMP4B, a fluorescently tagged component of the ESCRT-III complex. The ESCRT machinery, short for endosomal sorting complexes required for transport, is the cell’s emergency membrane-sealing system, recruited to sites of damage on both the plasma membrane and the nuclear envelope, where it patches holes within minutes. Defects in ESCRT proteins are linked to cancers and severe neurological diseases, and the machinery has also been implicated in helping tumor cells evade cytotoxic T-cell attack, making its dynamics directly relevant to human disease.

In untreated cells, CHMP4B was distributed diffusely throughout the cytoplasm, with the highest concentrations sitting inside the nucleus. After NEST treatment, that picture changed dramatically. The protein abandoned the nucleus and aggregated at the wound site, concentrating in the cytoplasmic space between the nuclear envelope and the plasma membrane. At its peak, the enrichment of CHMP4B at the repair site reached up to ten times the intensity measured in the nucleus, reflecting both accumulation at the wound and wholesale depletion from the nuclear interior. Three-dimensional reconstructions of confocal images confirmed that the aggregation occurred at a single localized region on the nuclear envelope surface.

The temporal choreography was equally revealing. Analyzing 97 cells across seven time points, the researchers found that the major recruitment of CHMP4B to wound sites occurred between one and five minutes after wounding. By ten minutes, the aggregates had dissipated and the protein’s distribution had returned to its pre-wounding state, with high intensity back inside the nucleus. Spatial heatmaps, built by aligning and averaging normalized images of many cells, showed that the CHMP4B signal during repair was concentrated closer to the nuclear envelope than to the plasma membrane, spanning the cytoplasm in a way never observed in studies of small wounds.

That spatial bias points to the study’s central finding: under extreme damage to both membranes, the cell preferentially allocates repair resources to the nuclear envelope. The authors suggest several possible reasons. The nuclear envelope is architecturally more complex than the plasma membrane, consisting of inner and outer lipid bilayers plus an underlying meshwork of lamin proteins that give the nucleus its structural rigidity. It is also the ultimate guardian of genomic integrity, so prioritizing its repair may protect the cell from catastrophic DNA exposure. Notably, the repair activity occurred on the cytosolic side of the rupture, with CHMP4B proteins that had resided in the nucleus translocating outward to seal the breach, and no significant activity was detected from within the nucleoplasm itself.

The depletion of nuclear CHMP4B is qualitatively different from what previous studies of small lesions reported, where the protein gathered at the rupture site while the nuclear pool remained intact. This suggests the existence of a wound severity threshold beyond which the cell must actively triage its repair resources, potentially limiting its capacity to fix multiple membrane systems at once. Such severity-dependent behavior would be invisible using conventional small-wound techniques, and it has direct implications for cancer biology, where tumor cells undergoing confined migration experience simultaneous, severe deformation of both membranes. Nuclear envelope rupture during migration can influence genomic stability and metastatic potential, so understanding how cells prioritize repair in this regime may illuminate how tumor cells survive their own aggressive journeys.

The study also addressed safety concerns about the technique itself. Measurements of pH2AX histone recruitment, a standard marker of double-stranded DNA breaks, showed no statistically significant difference between NEST-treated cells and untreated controls across more than 10,000 treated and 25,000 control cells, hinting that rapid ESCRT-mediated sealing may limit exposure of nuclear contents to the cytosol. The authors acknowledge limitations: the platform trades temporal resolution for throughput, the imaging analysis used 12 to 15 cells per time point, and the work was performed in HeLa cells, leaving generalization to primary and diseased cells for future study. Still, the researchers argue that the ability to generate controlled, severe wounds in high throughput opens new avenues for mapping the threshold between repair and regulated cell death, a question central to tissue injury, laminopathies, and the development of therapies that target membrane repair pathways in cancer.

Subject of Research: ESCRT-mediated repair of severe plasma membrane and nuclear envelope ruptures in mammalian cells

Article Title: High‐Throughput Mechanical Rupture of Nuclear Envelope and the Intracellular Dynamics of Massive Wound Repair

Article References: Fajrial, A. K., Akh, L., Schneider, S. E., Tan, W., Neu, C. P., & Ding, X. (2026). High‐Throughput Mechanical Rupture of Nuclear Envelope and the Intracellular Dynamics of Massive Wound Repair. Advanced Science, 13(55), Article e76561. https://doi.org/10.1002/advs.76561

Image Credits: AI Generated

DOI: 10.1002/advs.76561

Keywords: nuclear envelope, plasma membrane repair, ESCRT-III, CHMP4B, microfluidics, nanolancet, mechanoporation, cell wounding, cancer metastasis, HeLa cells, laminopathies, membrane rupture